Compensated Awareness Post View
Disclaimer
RBCC Sheds Light on Key Growth Plans, Engages New IR Group
Today before the opening bell, Rainbow Coral announced it is launching a new investor outreach campaign. The company has retained an up-and-coming, dynamic investor relations group committed to enhancing the visibility and reach of RBCC’s strategic growth initiatives.
“Our new investor relations partners have the hands-on expertise and industry relevance we need to thoroughly communicate our corporate plans and activities to current and potential investors as timely and efficiently as possible,” stated RBCC CEO Patrick Brown. “We’re confident that 2013 is shaping up to be an incredible year for RBCC, and we want to make sure that it doesn’t go unnoticed.”
Rainbow BioSciences, RBCC’s biotech division, has acquired a high interest in the Bio-Assembler, a biotech device owned by RBCC partner Nano3D BioSciences. This new technology enables scientists to grow cells in a three-dimensional environment using nanoparticles that produce magnetic fields to lift cells from the bottom of petri dishes.
The Bio-Assembler enables 3D cultures to form tissues that more closely resemble those found in the human body, versus conventional cell cultures grown on flat surfaces. The technology may help drastically reduce the cost of developing new drugs and eliminate the use of animal testing. Additionally, the Bio-Assembler has the potential to grow functional organs.
Rainbow Coral is closely working with its partner to further develop and market this profound technology worldwide. Retaining an investor relations group is part of the company’s plan to prepare for the execution of a far-reaching growth strategy.
For more information on Rainbow BioSciences, visit www.rainbowbiosciences.com/investors.html
